Creative Medical Technology Holdings, Inc. (CELZ)

CELZ Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 24, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	10	4	6	5	14	17
Market Cap Growth	139.40%	-36.61%	18.77%	-61.64%	-16.41%	2018.13%
Enterprise Value	5	-2	-6	-17	14	18
Last Close Price	2.72	2.31	4.61	3.81	22.10	139.00
PE Ratio	-	-	-	-	0.73	-
PS Ratio	1675.82	367.17	707.96	60.55	159.35	101.69
PB Ratio	1.26	0.64	0.62	0.34	1.37	-0.42
P/TBV Ratio	1.95	0.70	0.64	0.35	1.44	-
EV/Sales Ratio	782.27	-	-	-	163.74	107.06
Debt / Equity Ratio	0.00	0.00	0.00	0.00	0.00	-0.02
Asset Turnover	0.00	0.00	0.00	0.01	0.02	0.26
Inventory Turnover	1.09	1.00	0.43	2.71	-	-
Quick Ratio	20.57	18.13	26.89	5.54	10.21	0.00
Current Ratio	20.71	18.73	27.66	5.64	10.22	0.00
Return on Equity (ROE)	-98.14%	-65.85%	-40.34%	-77.78%	-	-
Return on Assets (ROA)	-59.68%	-41.30%	-23.49%	-42.05%	-32.60%	-111.61%
Return on Capital (ROIC)	-62.44%	-42.96%	-26.78%	-49.04%	-	-
Return on Capital Employed (ROCE)	-108.80%	-90.60%	-54.30%	-64.60%	-30.60%	2.80%
Earnings Yield	-59.29%	-136.01%	-82.97%	-189.10%	137.39%	-217.15%
Buyback Yield / Dilution	-52.66%	-5.17%	-28.76%	-236.51%	-460.63%	-

Updated Nov 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q